Lixte Biotechnology Holdings, I (LIXT) Financials

LIXT Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 5.2 million 311736
2023-06-30 3.1 million 402614
2023-03-31 4.3 million 249987
2022-12-31 5.6 million 394786

LIXT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -944389 112106
2023-06-30 -1.2 million 280060
2023-03-31 -1.3 million 276980
2022-12-31 -1.2 million 385391

LIXT Net Income

No data available :(

LIXT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 5.1 million - -
2023-06-30 2.9 million - -
2023-03-31 4.1 million - -
2022-12-31 5.4 million - -

LIXT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 2.1 million
2023-06-30 1.7 million
2023-03-31 1.7 million
2022-12-31 1.7 million

LIXT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 132487 534013 -
2023-06-30 - 427457 862571 -
2023-03-31 - 189085 1.2 million -
2022-12-31 - 453620 1.2 million -

LIXT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -

LIXT

Price: $2.85

52 week price:
1.58
9.50

Earnings Per Share: -2.66 USD

P/E Ratio: -0.64

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 110300

Market Capitalization: 7.6 million

Links: